Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Genor Biopharma Co., Ltd.
Scientific Title
A Phase I/II, First-in-Human, Open-Label, Multicenter Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of a Trispecific EGFR/cMET/cMET Antibody GB263T in Subjects With Advanced Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors